Bronchopulmonary Dysplasia Clinical Trials

48 recruitingLast updated: June 18, 2026

There are 48 actively recruiting bronchopulmonary dysplasia clinical trials across 24 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1, Phase 4. Top locations include Kansas City, Missouri, United States, Indianapolis, Indiana, United States, Toronto, Ontario, Canada. Updated daily from ClinicalTrials.gov.


Bronchopulmonary Dysplasia Trials at a Glance

48 actively recruiting trials for bronchopulmonary dysplasia are listed on ClinicalTrialsFinder across 6 cities in 24 countries. The largest study group is Not Applicable with 13 trials, with the heaviest enrollment activity in Kansas City, Indianapolis, and Toronto. Lead sponsors running bronchopulmonary dysplasia studies include Children's Hospital of Philadelphia, Duke University, and International Peace Maternity and Child Health Hospital.

Browse bronchopulmonary dysplasia trials by phase

Treatments under study

About Bronchopulmonary Dysplasia Clinical Trials

Looking for clinical trials for Bronchopulmonary Dysplasia? There are currently 37 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bronchopulmonary Dysplasia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bronchopulmonary Dysplasia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 48 trials

Recruiting
Not Applicable

Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants

Pulmonary HypertensionBronchopulmonary Dysplasia
University of Alabama at Birmingham39 enrolled2 locationsNCT06373289
Recruiting
Phase 4

Enteral Lipid Supplementation and Bronchoplumonary Dysplasia of Premature Infants

Bronchopulmonary Dysplasia (BPD)
Aristotle University Of Thessaloniki74 enrolled1 locationNCT07652684
Recruiting
Phase 2

A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants

Intraventricular hemorrhageChronic lung disease of prematurityBronchopulmonary Dysplasia+1 more
OHB Neonatology Ltd.338 enrolled72 locationsNCT03253263
Recruiting
Phase 1

Pharmacokinetics and Placental Transfer of Caffeine

Apnea of PrematurityPremature BirthBronchopulmonary Dysplasia+2 more
Indiana University30 enrolled1 locationNCT07570121
Recruiting

Lung Ultrasound Score for Early Prediction of Bronchopulmonary Dysplasia in Preterm Newborns

Bronchopulmonary Dysplasia
Azienda USL Reggio Emilia - IRCCS40 enrolled4 locationsNCT07633184
Recruiting
Phase 2Phase 3

Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)

Bronchopulmonary Dysplasia
Airway Therapeutics, Inc.366 enrolled50 locationsNCT06897839
Recruiting
Phase 1Phase 2

PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia

Critical IllnessBronchopulmonary Dysplasia (BPD)Premature Births
Duke University28 enrolled5 locationsNCT07101640
Recruiting

Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease

Bronchopulmonary Dysplasia
Boston Children's Hospital50 enrolled1 locationNCT05285345
Recruiting
Phase 2

IVIG Trial for the Treatment of Bronchopulmonary Dysplasia

Bronchopulmonary Dysplasia
International Peace Maternity and Child Health Hospital20 enrolled1 locationNCT06925360
Recruiting
Not Applicable

Ventilator Pressure and Optimization of Compliance and Hemodynamics

Pulmonary Hypertension Due to Lung Diseases and HypoxiaBronchopulmonary DysplasiaExtreme Prematurity+2 more
University of Alabama at Birmingham24 enrolled1 locationNCT06512935
Recruiting
Not Applicable

Restricted Versus Liberal Fluid Intake for Prevention of Bronchopulmonary Dysplasia

Bronchopulmonary Dysplasia
University Children's Hospital Basel750 enrolled9 locationsNCT06954142
Recruiting
Phase 2

Lipid Infusions to Optimize Nutrition Trial

Bronchopulmonary Dysplasianeurodevelopmental impairment
The University of Texas Health Science Center, Houston230 enrolled1 locationNCT06915441
Recruiting
Not Applicable

Safety and PK-PD Study of Oral L-CIT in Preterm Infants With BPD±PH and NEC

Pulmonary HypertensionBPD - Bronchopulmonary DysplasiaNEC
The Hospital for Sick Children36 enrolled1 locationNCT05636397
Recruiting
Phase 2

Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and Below

Bronchopulmonary Dysplasia
International Peace Maternity and Child Health Hospital29 enrolled1 locationNCT07561125
Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting
Phase 1

Inhaled Ciclesonide Study in Preterm Infants

Bronchopulmonary Dysplasia
Venkatesh Sampath30 enrolled1 locationNCT06589245
Recruiting

Prospective Multicentre Mixed Methods Study to Explore Extubation Practices and Respiratory Outcomes in Extremely Preterm Neonates.

extubation failurePreterm neonateMechanical Ventilation+3 more
Centre Hospitalier Intercommunal Creteil100 enrolled31 locationsNCT06808997
Recruiting

Pressure-Sensing Mattresses and Mechanical Ventilation Weaning in Neonatal

Bronchopulmonary Dysplasia
Fu Jen Catholic University60 enrolled1 locationNCT06579157
Recruiting

Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and Mortality

Intraventricular hemorrhageDeathPulmonary Hemorrhage+5 more
University Hospital, Montpellier30 enrolled1 locationNCT07273643
Recruiting

National Surveillance and Prevention of Neonatal VAP

Bronchopulmonary Dysplasia (BPD)Ventilator-Associated Pneumonia (VAP), NeonatalAntibiotic-Resistant Organisms (AROs)+1 more
University of Alberta1,500 enrolled1 locationNCT07109791